EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation

Nathiphat Tanwattana, Nanchaya Wanasen, Yuparat Jantraphakorn, Kanjana Srisutthisamphan, Thanathom Chailungkarn iD, Suwimon Boonrungsiman, Boonlert Lumlertdacha, Porntippa Lekchareonsuk, Challika Kaewborisuth iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0292833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Nathiphat Tanwattana und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Program in Genetic Engineering and Bioinformatics, Graduate School, Kasetsart University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Rabies virus, Rabies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand Science Research and Innovation, Kasetsart University Research and Development Institute, Agricultural Research and Development Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The innate immune response is a first-line defense mechanism triggered by rabies virus (RABV). Interferon (IFN) signaling and ISG products have been shown to confer resistance to RABV at various stages of the virus’s life cycle. Human tetherin, also known as bone marrow stromal cell antigen 2 (hBST2), is a multifunctional transmembrane glycoprotein induced by IFN that has been shown to effectively counteract many viruses through diverse mechanisms. Here, we demonstrate that hBST2 inhibits RABV budding by tethering new virions to the cell surface. It was observed that release of virus-like particles (VLPs) formed by RABV G (RABV-G VLPs), but not RABV M (RABV-G VLPs), were suppressed by hBST2, indicating that RABV-G has a specific effect on the hBST2-mediated restriction of RABV. The ability of hBST2 to prevent the release of RABV-G VLPs and impede RABV growth kinetics is retained even when hBST2 has mutations at dimerization and/or glycosylation sites, making hBST2 an antagonist to RABV, with multiple mechanisms possibly contributing to the hBST2-mediated suppression of RABV. Our findings expand the knowledge of host antiviral mechanisms that control RABV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rabies virusRabiesHumansGlycosylationAsparagineCysteineDimerizationVirus ReleaseBone Marrow Stromal Antigen 2Antigens, CDGPI-Linked Proteins

Substanzen

AsparagineCysteineBone Marrow Stromal Antigen 2BST2 protein, humanAntigens, CDGPI-Linked Proteins

Autor:innen und Institutionen

  • Interdisciplinary Program in Genetic Engineering and Bioinformatics, Graduate School, Kasetsart University, Bangkok, Thailand.
  • Virology and Cell Technology Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathumthani, Thailand.
  • National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), KlongLuang, Pathum Thani, Thailand.
  • Queen Saovabha Memorial Institute, Thai Red Cross Society, WHO Collaborating Center for Research and Training Prophylaxis on Rabies, Pathumwan, Bangkok, Thailand.
  • Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand.
  • Center for Advance Studies in Agriculture and Food, KU Institute Studies, Kasetsart University, Bangkok, Thailand.

ORCID-Profile: Thanathom Chailungkarn, Challika Kaewborisuth

Förderung

  • Thailand Science Research and Innovation
  • Kasetsart University Research and Development Institute
  • Agricultural Research and Development Agency

Zitieren

APA

Tanwattana, N., Wanasen, N., Jantraphakorn, Y., Srisutthisamphan, K., Chailungkarn, T., Boonrungsiman, S., Lumlertdacha, B., Lekchareonsuk, P., & Kaewborisuth, C. (2023). Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation. PLOS ONE. https://doi.org/10.1371/journal.pone.0292833

Vancouver

Tanwattana N, Wanasen N, Jantraphakorn Y, Srisutthisamphan K, Chailungkarn T, Boonrungsiman S, et al. Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation. PLOS ONE. 2023. doi:10.1371/journal.pone.0292833

BibTeX
@article{Tanwattana2023,
  author = {Tanwattana, Nathiphat and Wanasen, Nanchaya and Jantraphakorn, Yuparat and Srisutthisamphan, Kanjana and Chailungkarn, Thanathom and Boonrungsiman, Suwimon and Lumlertdacha, Boonlert and Lekchareonsuk, Porntippa and Kaewborisuth, Challika},
  title = {Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0292833}
}
Kostenlos starten →